高纯度 2,3 - 二氯喹喔啉 2213-63-0 抗肿瘤药物中间体液晶显示材料原料山西永津 新品

山西永津集团有限公司稳定供应2,3 - 二氯喹喔啉（CAS2213-63-0，别名 2,3 - 二氯喹恶啉、2,3 - 二氯苯并吡嗪），产品纯度稳定≥99%，灰色结晶固体，杂质含量低、批次一致性强，可提供全套 COA 质检报告、合规资质文件，支持 1kg 试样、25kg 纸板桶标准包装及吨级大批量现货直发。本品属于高活性氯代喹喔啉杂环单体，可发生亲核芳香取代反应，下游应用覆盖多核心行业：医药领域是喹喔啉类衍生物核心合成原料，用于抗肿瘤、防癌先导药物、抗炎抗病毒原料药制备，也用于心脑血管、抑菌类新药合成；分析化学领域用于固相合成制备 HPLC 高效液相手性固定相，色谱分离填料关键中间体；电子新材料行业作为液晶显示材料、有机光电薄膜合成单体；农药领域合成广谱抑菌、除草类杂环农药及植物病害防治中间体；精细有机合成用于各类单取代、双取代喹喔啉衍生物搭建；科研实验室用作有机合成标准底物、新药研发模板原料；同时可制备甾体稠合喹喔啉杂环、硫代嘧啶类医药中间体。集团自有标准化杂环化工生产线，库存充足、交付周期短，长期为国内外制药、光电液晶、农药、色谱试剂企业稳定供货。

Shanxi Yongjin Group Co., Ltd. stably supplies 2,3-Dichloroquinoxaline (CAS 2213-63-0, also named 2,3-dichloroquinoxazoline, 2,3-dichlorobenzopyrazine) with purity over 99%. It is gray crystalline solid with low impurities and consistent batch indicators. We provide full COA test certificates and compliance documents, supporting 1kg lab samples, 25kg fiber drum standard packages and bulk ton-level spot delivery. As highly active chlorinated quinoxaline heterocyclic monomer, it undergoes nucleophilic aromatic substitution reaction, widely applied in multiple core industries: In pharmaceutical field, it is core raw material for quinoxaline derivatives, applied in anti-tumor, cancer chemopreventive lead compounds, anti-inflammatory and antiviral APIs, as well as cardiovascular and antibacterial new drugs; In analytical chemistry, it is adopted in solid-phase synthesis to manufacture HPLC chiral stationary phases, key intermediate for chromatographic separation fillers; For electronic new materials, it serves as synthetic monomer for liquid crystal display materials and organic optoelectronic films; In pesticide industry, it synthesizes broad-spectrum bacteriostatic, herbicidal heterocyclic pesticides and crop disease control intermediates; For fine organic synthesis, it builds various mono- and disubstituted quinoxaline derivatives; In research labs, it acts as standard substrate for organic synthesis and template raw material for new drug research; It can also synthesize steroid fused quinoxaline heterocycles and thiopyrimidine pharmaceutical intermediates. Our group owns standardized heterocyclic chemical production lines with sufficient inventory and short lead time, offering long-term stable supply for pharmaceutical, optoelectronic liquid crystal, pesticide and chromatographic reagent enterprises worldwide.